Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study

References

• Shimura M, Yasuda K, Nakazawa T, Shiono T, Nishida K. Panretinal-photocoagulation before pars plana vitrectomy influences vitreous level of interleukin-6 but not of vascular endothelial growth factor in patients with diabetic retinopathy. Int J Biomed Sci. 2007;3(1):31–37.
   PubMedGoogle Scholar
• Gupta A, Bansal R, Gupta V, Dogra MR. Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab. Int Ophthalmol. 2012;32(2):135–144. doi:10.1007/s10792-012-9541-5
   PubMed Web of Science ®Google Scholar
• The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8. Ophthalmology. 1981;88(7):583–600.
   PubMed Web of Science ®Google Scholar
• Kaiser RS, Maguire MG, Grunwald JE, et al. One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy. Am J Ophthalmol. 2000;129(2):178–185. doi:10.1016/s0002-9394(99)00322-0
   PubMed Web of Science ®Google Scholar
• Chappelow AV, Tan K, Waheed NK, Kaiser PK. Panretinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser. Am J Ophthalmol. 2012;153(1):137–42 e2. doi:10.1016/j.ajo.2011.05.035
   PubMed Web of Science ®Google Scholar
• Parikh R, Shah RJ, VanHouten JP, Cherney EF. Ocular findings at initial pan retinal photocoagulation for proliferative diabetic retinopathy predict the need for future pars plana vitrectomy. Retina. 2014;34(10):1997–2002. doi:10.1097/IAE.0000000000000192
   PubMed Web of Science ®Google Scholar
• The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. Arch Ophthalmol. 1985;103(11):1644–1652. doi:10.1001/archopht.1985.01050110038020
   PubMedGoogle Scholar
• Gupta B, Sivaprasad S, Wong R, et al. Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK study. Eye. 2012;26(4):510–516. doi:10.1038/eye.2011.321
   PubMed Web of Science ®Google Scholar
• Gupta B, Wong R, Sivaprasad S, Williamson TH. Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice. Eye. 2012;26(4):576–582. doi:10.1038/eye.2011.348
   PubMed Web of Science ®Google Scholar
• The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 3. Ophthalmology. 1988;95(10):1307–1320. doi:10.1016/s0161-6420(88)33015-0
   PubMed Web of Science ®Google Scholar
• Yorston D, Wickham L, Benson S, Bunce C, Sheard R, Charteris D. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol. 2008;92(3):365–368. doi:10.1136/bjo.2007.124495
   PubMed Web of Science ®Google Scholar
• Khuthaila MK, Hsu J, Chiang A, et al. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy. Am J Ophthalmol. 2013;155(4):757–63, 63 e1–2. doi:10.1016/j.ajo.2012.11.004
   Web of Science ®Google Scholar
• Bach M. The Freiburg visual acuity test-variability unchanged by post-hoc re-analysis. Graefes Arch Clin Exp Ophthalmol. 2007;245(7):965–971. doi:10.1007/s00417-006-0474-4
   PubMed Web of Science ®Google Scholar
• Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47(3):1236–1240. doi:10.1167/iovs.05-0981
   PubMed Web of Science ®Google Scholar
• Gross JG, Glassman AR, Liu D, et al. Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA Ophthalmol. 2018;136(10):1138–1148. doi:10.1001/jamaophthalmol.2018.3255
   PubMed Web of Science ®Google Scholar
• Antoszyk AN, Glassman AR, Beaulieu WT, et al. Effect of intravitreous aflibercept vs vitrectomy with panretinal photocoagulation on visual acuity in patients with vitreous hemorrhage from proliferative diabetic retinopathy: a randomized clinical trial. JAMA. 2020;324(23):2383–2395. doi:10.1001/jama.2020.23027
   PubMed Web of Science ®Google Scholar
• Glassman AR, Beaulieu WT, Maguire MG, et al. Visual acuity, vitreous hemorrhage, and other ocular outcomes after vitrectomy vs aflibercept for vitreous hemorrhage due to diabetic retinopathy: a secondary analysis of a randomized clinical trial. JAMA Ophthalmol. 2021;139(7):725–733. doi:10.1001/jamaophthalmol.2021.1110
   PubMed Web of Science ®Google Scholar
• Hamanaka T, Akabane N, Yajima T, Takahashi T, Tanabe A. Retinal ischemia and angle neovascularization in proliferative diabetic retinopathy. Am J Ophthalmol. 2001;132(5):648–658. doi:10.1016/s0002-9394(01)01108-4
   PubMed Web of Science ®Google Scholar
• Liao M, Wang X, Yu J, et al. Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients. BMC Ophthalmol. 2020;20(1):416. doi:10.1186/s12886-020-01688-3
   PubMed Web of Science ®Google Scholar
• Ryan A, Saad T, Kirwan C, Keegan DJ, Acheson RW. Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery. Clin Exp Ophthalmol. 2013;41(4):387–395. doi:10.1111/ceo.12017
   PubMed Web of Science ®Google Scholar
• Lauermann P, Klingelhöfer A, Mielke D, et al. Risk factors for severe bleeding complications in vitreoretinal surgery and the role of antiplatelet or anticoagulant agents. Ophthalmol Retina. 2021;5(8):e23–e29. doi:10.1016/j.oret.2021.04.013
   PubMedGoogle Scholar
• Narendran N, Williamson TH. The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery. Acta Ophthalmol Scand. 2003;81(1):38–40. doi:10.1034/j.1600-0420.2003.00020.x
   PubMedGoogle Scholar
• Degenring RF, Kreissig I, Jonas JB. Intraokulare Triamcinolongabe bei diffusem diabetischen Makulaödem [Intraocular triamcinolone for diffuse diabetic macular edema]. Ophthalmology. 2004;101(3):251–254. German. doi:10.1007/s00347-003-0862-7
   Google Scholar
• Koga T, Mawatari Y, Inumaru J, Fukushima M, Tanihara H. Trans-Tenon’s retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2005;243(12):1247–1252. doi:10.1007/s00417-005-0045-0
   PubMed Web of Science ®Google Scholar
• Cheema RA, Mushtaq J, Al-Khars W, Al-Askar E, Cheema MA. Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage. Retina. 2010;30(10):1646–1650. doi:10.1097/IAE.0b013e3181d6def0
   PubMed Web of Science ®Google Scholar
• Nakamura A, Shimada Y, Horio N, Horiguchi M. Vitrectomy for diabetic macular edema with posterior subtenon injection of triamcinolone acetonide. Folia Ophthalmologica Japonica. 2004;55(12):958–962.
   Google Scholar
• Novak MA, Rice TA, Michels RG, Auer C. Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology. 1984;91(12):1485–1489. doi:10.1016/s0161-6420(84)34099-4
   PubMed Web of Science ®Google Scholar
• Schachat AP, Oyakawa RT, Michels RG, Rice TA. Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology. 1983;90(5):522–530. doi:10.1016/s0161-6420(83)34540-1
   PubMed Web of Science ®Google Scholar
• Rush RB, Velazquez JC, Rosales CR, Rush SW. Gas tamponade for the prevention of postoperative vitreous hemorrhaging after diabetic vitrectomy: a randomized clinical trial. Am J Ophthalmol. 2022;242:173–180. doi:10.1016/j.ajo.2022.06.015
   PubMed Web of Science ®Google Scholar